REMUS

Remus Pharmaceuticals Share Price Remus Pharmaceuticals

₹7,838.4
+4.75 (0.06%)
28 April, 2024 12:47 BSE: NSE: REMUSISIN: INE0O5T01011

Start SIP in Remus Pharmaceuticals

Start SIP

Remus Pharmaceuticals Performance

Day Range

  • Low 7,500
  • High 8,050
₹ 7,838

52 Week Range

  • Low 1,711
  • High 8,747
₹ 7,838
  • Open Price7,800
  • Previous Close7,834
  • Volume4400

Remus Pharmaceuticals Share Price

  • Over 1 Month +28.3%
  • Over 3 Month +28.37%
  • Over 6 Month +40%
  • Over 1 Year +537.79%

Remus Pharmaceuticals Key Statistics

P/E Ratio
PEG Ratio
Market Cap Cr 1,155
Price to Book Ratio 60.3
EPS 57.7
Dividend 0
Relative Strength Index 68.61
Money Flow Index 84.81
MACD Signal 162.12
Average True Range 561.66
Remus Pharmaceuticals Financials
IndicatorMar 2023
Total Revenue Annual Cr 47
Operating Expenses Annual Cr 34
Operating Profit Annual in Cr 11
Depreciation Cr 0
Interest Annual Cr 0
Tax Annual Cr 3
Net Profit Annual Cr 9
IndicatorMar 2023
Cash from Operating Activity Annual Cr 5
Cash from Investing Activity Annual Cr -15
Cash from Financing Annual Activity Cr 12
Net Cash Flow Annual Cr 2
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 19
Fixed Assets Annual Cr 3
Total Non Current Assets Annual Cr 23
Total Current Assets Annual Cr 11
Total Assets Annual Cr 35
IndicatorMar 2023
Book Value Per Share Annual Rs 176
ROE Annual % 44
ROCE Annual % 44
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 27
IndicatorMar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual -
EBDIT Annual Margin %

Remus Pharmaceuticals Technicals

EMA & SMA

Current Price
₹7,838.4
+4.75 (0.06%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹6,632.43
  • 50 Day
  • ₹6,366.73
  • 100 Day
  • ₹6,127.33
  • 200 Day
  • ₹5,363.20
  • 20 Day
  • ₹6,531.06
  • 50 Day
  • ₹6,222.40
  • 100 Day
  • ₹6,382.08
  • 200 Day
  • ₹5,535.26

Remus Pharmaceuticals Resistance and Support

PIVOT
₹7,796.14
Resistance
First Resistance 8,092.27
Second Resistance 8,346.13
Third Resistance 8,642.27
RSI 68.61
MFI 84.81
MACD Single Line 162.12
MACD 380.70
Support
First Resistance 7,542.27
Second Resistance 7,246.13
Third Resistance 6,992.27

Remus Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 4,400 275,000 62.5
Week 10,860 568,955 52.39
1 Month 4,417 260,918 59.07
6 Month 2,401 160,639 66.91

Remus Pharmaceuticals Result Highlights

Remus Pharmaceuticals Synopsis

Market Cap
Sales
Shares in Float
No of funds
Yield
Book Value
U/D Vol ratio
LTDebt / Equity
Alpha
Beta

Remus Pharmaceuticals

Owner Name

Remus Pharmaceuticals Management

Name Designation

Remus Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Remus Pharmaceuticals Corporate Action

Date Purpose Remarks
2024-04-23 Bonus issue & Interim Dividend
2024-04-22 Interim Dividend
Date Purpose Remarks
2023-10-28 INTERIM Rs.0.00 Interim Dividend of Rs. 2 per equity share.

Remus Pharmaceuticals MF Shareholding

Name Amount(cr)

Remus Pharmaceuticals FAQs

What is Share Price of Remus Pharmaceuticals ?

Remus Pharmaceuticals share price is ₹7,838 As on 28 April, 2024 | 12:33

What is the Market Cap of Remus Pharmaceuticals ?

The Market Cap of Remus Pharmaceuticals is ₹1154.6 Cr As on 28 April, 2024 | 12:33

What is the P/E ratio of Remus Pharmaceuticals ?

The P/E ratio of Remus Pharmaceuticals is As on 28 April, 2024 | 12:33

What is the PB ratio of Remus Pharmaceuticals ?

The PB ratio of Remus Pharmaceuticals is 60.3 As on 28 April, 2024 | 12:33

Q2FY23